BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2004
View Archived Issues
Synergistic effects of MB40 in prostate cancer models
Read More
Two new human monoclonal anticollagen antibodies from CancerVax inhibit tumor growth in vivo
Read More
Neuroprotective effects of FR-255595, a PARP-1 inhibitor, reported by Fujisawa
Read More
ImClone presents an anti-VEGFR-1 antibody effective against human breast cancers in vivo
Read More
IMC-11F8, an anti-EGFR monoclonal antibody, effective antitumor agent in vivo
Read More
KID3, a glycotope-specific IgG monoclonal antibody, inhibits colon and gastric tumor growth
Read More
Small potent BACE1 inhibitors against beta-amyloid plaque formation
Read More
Three series of DPP-IV inhibitors prepared and tested at Boehringer Ingelheim
Read More
Merckle scientists present two series of p38 MAP kinase inhibitors
Read More
New inhibitors of 5-HT and/or NE reuptake and their use in pain and other disorders
Read More
Lilly claims NE reuptake inhibitors with potential in ADHD therapy
Read More
New CRF1 modulators in early development at Neurogen
Read More
Celltech patent covers novel IMPDH inhibitors and their use
Read More
HCT-1026 reduces beta-amyloid deposition in mouse model of Alzheimer's
Read More
Genome Therapeutics changes name to Oscient Pharmaceuticals
Read More
Approval for treatment protocol for Ceplene plus IL-2 in malignant melanoma
Read More
Fuzeon to be made available through U.S. pharmacies
Read More
Accentia enters licensing agreements for chronic rhinosinusitis
Read More
Norak Biosciences and Scynexis enter chemistry collaboration
Read More
Oxxon Therapeutics, new name for Oxxon Pharmaccines
Read More
SBIR grant supports Kosan's development of next-generation Hsp90 inhibitors
Read More
Subcutaneous icatibant produces positive results in bioavailability study
Read More
Myriad Genetics licenses rights to new colon cancer gene MYH
Read More
Health Canada approves extension study of Tectin
Read More
Zadaxin in combination with lamivudine investigated for hepatitis B
Read More
Mixed initial results for Fampridine-SR in MS and spinal cord injury
Read More
FDA approval for ChiRhoClin's human secretin
Read More
Torcetrapib increases HDL cholesterol levels and may be beneficial for CHD patients
Read More
Alicaforsen reported effective for chronic pouchitis following anastomosis for ulcerative colitis
Read More
Clinical trials confirm the benefits of cinacalcet in secondary HPT
Read More
Promising compounds against drug-resistant tuberculosis
Read More